A 2023 study published in the Journal of Hepatology reported on a Phase IIa trial aimed at evaluating the efficacy and safety of efinopegdutide in patients with NAFLD, comparing it to semaglutide
This combination is often explored in laboratory settings focused on multi-pathway research
Chokshi SN, Hou N, Ford MC, Crockarell JR, Mihalko JL, Holland CT
We know that insulin dysregulation can contribute to the development of Alzheimer's disease, dementia.[00:22:00] The other thing that's interesting about seeing that they're lowering inflammation, they're helping with brain energy, is that this may show promise for women who have A DHD because we know women who have A DHD, they struggle with brain energy and neuroinflammation
If those underlying drivers are not addressed, no peptide, no supplement, and no treatment will ever deliver what it is capable of delivering
Came quick and sealed correctly